Collectively, these approaches may help unravel the molecular, cellular, and contextual determinants of NLRP3 signaling and could guide the development of safer, context-specific therapeutic interventions for infections, autoinflammatory diseases and cancer. This evidence concerns the gene NLRP3 and cancer.